Skip to content
Home / Companies / FTRE FTR
Fortrea Holdings Inc. (FTRE) XNAS SERVICES-MEDICAL LABORATORIES Net insider selling (90d)
Latest FTRE Insider Trades
About Fortrea Holdings Inc. (FTRE) Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
Headquarters DURHAM, NC
Employees 14,000
Listed 2023
Exchange XNAS https://www.fortrea.com SEC filings for FTRE on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 9 240,724 $4.43M Grant or award 8 105,804 Option exercise 19 1,294,750
FTRE Insider Transactions (Form 4) 74 42 Form 4 filings on record, the earliest from Dec 17, 2024, newest first. Filing history page 1 of 2.
Date Insider Transaction Security Shares Price Value Aug 18, 2026 MM Mark A. Morais - Officer Option exercise Common Stock 11,313
Recent FTRE Form 8-K Filings 5
Recent FTRE Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 19, 2026 Mcconnell Jill G. Officer 4,892 $89K View on EDGAR Aug 19, 2026 Morais Mark A. Officer
FTRE Insider Trading - FAQ
What is the latest insider trade for FTRE? Fortrea Holdings Inc. (FTRE) had 16 insider filings in the last 90 days, with the most recent on 2026-08-19. The full record for FTRE runs to 42 Form 4 filings, the earliest from 2024-12-17. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying FTRE stock? No insider purchases of FTRE were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling FTRE stock? 9 insider sales of FTRE were filed in the last 90 days, totaling $4.43M.
Where can I see FTRE SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks FTRE Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow FTRE insider buys? Create a free InsiderAlpha account and press Watch on this page to add FTRE to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track FTRE insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free $1.02M
Market cap $1.79B
P/E ratio -
Dividend yield -
Average volume 1.46M
52 week high $21.39
52 week low $8.31
Today's high $19.14
Today's low $18.46
Open $18.77
Volume 1.14M
Previous close $18.86
Shares outstanding 95.10M Market cap
$1.79B
14,000 employees
FTRE Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 9 sales totaling $4.43M.
Most-Active FTRE Insiders - Last 90 Days 10 Tax withholding / forfeiture 1 18,244
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Aug 19, 2026 MM Mark A. Morais - Officer Open-market sale Common Stock 4,892 $18.19 $89K
Aug 18, 2026 MM Mark A. Morais - Officer Option exercise Restricted Stock Unit 11,313 $0.00 -
Aug 6, 2026 AT Anshul Thakral - Officer Open-market sale Common Stock 55,882 $18.17 $1.02M
Aug 6, 2026 AT Anshul Thakral - Officer Open-market sale Common Stock 55,975 $18.06 $1.01M
Aug 4, 2026 AT Anshul Thakral - Officer Option exercise Common Stock 416,666 $0.00 -
Aug 5, 2026 AT Anshul Thakral - Officer Open-market sale Common Stock 49,452 $19.03 $941K
Aug 5, 2026 AT Anshul Thakral - Officer Open-market sale Common Stock 50,417 $19.28 $972K
Aug 4, 2026 AT Anshul Thakral - Officer Option exercise Restricted Stock Unit 416,666 $0.00 -
Aug 3, 2026 DS David Ross Smith - Officer Grant or award Restricted Stock Unit 15,840 $0.00 -
Aug 3, 2026 MS Machelle Sanders - Director Open-market sale Common Stock 9,700 $18.01 $175K
Jun 10, 2026 MS Machelle Sanders - Director Option exercise Restricted Stock Unit 38,817 $0.00 -
Jun 10, 2026 MS Machelle Sanders - Director Grant or award Restricted Stock Unit 12,852 $0.00 -
Jun 10, 2026 MS Machelle Sanders - Director Option exercise Common Stock 38,817 $0.00 -
Jun 10, 2026 DS David Ross Smith - Director Option exercise Common Stock 38,817 $0.00 -
Jun 10, 2026 DS David Ross Smith - Director Tax withholding / forfeiture Common Stock 18,244 $16.34 $298K
Jun 10, 2026 DS David Ross Smith - Director Option exercise Restricted Stock Unit 38,817 $0.00 -
Jun 10, 2026 DS David Ross Smith - Director Grant or award Restricted Stock Unit 12,852 $0.00 -
Jun 10, 2026 EP Edward A. Pesicka - Director Option exercise Restricted Stock Unit 38,817 $0.00 -
Jun 10, 2026 EP Edward A. Pesicka - Director Grant or award Restricted Stock Unit 12,852 $0.00 -
Jun 10, 2026 PN Peter M. Neupert - Director Grant or award Restricted Stock Unit 12,852 $0.00 -
Jun 10, 2026 MM Mark A. Morais - Officer Open-market sale Common Stock 4,674 $16.82 $79K
Jun 10, 2026 AR Amrit Ray - Director Option exercise Restricted Stock Unit 38,817 $0.00 -
Jun 10, 2026 AR Amrit Ray - Director Grant or award Restricted Stock Unit 12,852 $0.00 -
Jun 10, 2026 AR Amrit Ray - Director Option exercise Common Stock 38,817 $0.00 -
Jun 10, 2026 ER Erin L. Russell - Director Option exercise Restricted Stock Unit 38,817 $0.00 -
Jun 10, 2026 ER Erin L. Russell - Director Grant or award Restricted Stock Unit 12,852 $0.00 -
Jun 10, 2026 ER Erin L. Russell - Director Option exercise Common Stock 38,817 $0.00 -
Jun 1, 2026 MM Mark A. Morais - Officer Option exercise Common Stock 11,006 $0.00 -
Jun 2, 2026 MM Mark A. Morais - Officer Open-market sale Common Stock 4,866 $15.49 $75K
Jun 1, 2026 MM Mark A. Morais - Officer Option exercise Restricted Stock Unit 11,006 $0.00 -
Jun 1, 2026 JM Jill G. McConnell - Officer Option exercise Restricted Stock Unit 11,006 $0.00 -
May 18, 2026 RP Robert Parks - Officer Open-market sale Common Stock 2,000 $13.44 $27K
May 14, 2026 PN Peter M. Neupert - Director Option exercise Common Stock 148,536 $0.00 -
May 14, 2026 PN Peter M. Neupert - Director Option exercise Restricted Stock Unit 148,536 $0.00 -
Mar 20, 2026 ER Erin L. Russell - Director Option exercise Common Stock 23,946 $0.00 -
Mar 20, 2026 ER Erin L. Russell - Director Option exercise Restricted Stock Unit 23,946 $0.00 -
Mar 13, 2026 MM Mark A. Morais - Officer Option exercise Common Stock 4,284 $0.00 -
Mar 16, 2026 MM Mark A. Morais - Officer Open-market sale Common Stock 1,804 $9.22 $17K
Mar 13, 2026 MM Mark A. Morais - Officer Option exercise Restricted Stock Unit 4,284 $0.00 -
Mar 13, 2026 JM Jill G. McConnell - Officer Option exercise Restricted Stock Unit 4,284 $0.00 -
Mar 9, 2026 RP Robert Parks - Officer Option exercise Common Stock 5,270 $0.00 -
Mar 10, 2026 RP Robert Parks - Officer Open-market sale Common Stock 963 $8.93 $9K
Mar 10, 2026 RP Robert Parks - Officer Open-market sale Common Stock 964 $9.21 $9K
Mar 9, 2026 RP Robert Parks - Officer Option exercise Restricted Stock Unit 5,270 $0.00 -
Mar 10, 2026 MM Mark A. Morais - Officer Open-market sale Common Stock 2,299 $8.93 $21K
Mar 10, 2026 MM Mark A. Morais - Officer Open-market sale Common Stock 2,300 $9.21 $21K
Mar 9, 2026 MM Mark A. Morais - Officer Option exercise Restricted Stock Unit 13,966 $0.00 -
Mar 9, 2026 MM Mark A. Morais - Officer Option exercise Common Stock 13,966 $0.00 -
Mar 9, 2026 JM Jill G. McConnell - Officer Option exercise Restricted Stock Unit 15,283 $0.00 -
Mar 6, 2026 RP Robert Parks - Officer Grant or award Restricted Stock Unit 22,893 $0.00 -
Mar 6, 2026 MM Mark A. Morais - Officer Grant or award Restricted Stock Unit 52,030 $0.00 -
Mar 6, 2026 MM Mark A. Morais - Officer Grant or award Performance Stock Units 66,667 $0.00 -
Mar 6, 2026 JM Jill G. McConnell - Officer Grant or award Restricted Stock Unit 88,450 $0.00 -
Mar 6, 2026 JM Jill G. McConnell - Officer Grant or award Performance Stock Units 66,667 $0.00 -
Feb 9, 2026 MM Mark A. Morais - Officer Option exercise Common Stock 2,255 $0.00 -
Feb 10, 2026 MM Mark A. Morais - Officer Open-market sale Common Stock 589 $13.65 $8K
Feb 10, 2026 MM Mark A. Morais - Officer Open-market sale Common Stock 590 $14.11 $8K
Feb 9, 2026 MM Mark A. Morais - Officer Option exercise Restricted Stock Unit 2,255 $0.00 -
Feb 9, 2026 JM Jill G. McConnell - Officer Option exercise Restricted Stock Unit 1,685 $0.00 -
Aug 6, 2026 Thakral Anshul Officer, Director 111,857 $2.03M View on EDGAR
$CELC
Celcuity Inc.
Anshul Thakral - OfficerOpen-market sale
